Loading...

Atlantic International Corp.

ATLN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$1.70
$-0.05(-3.13%)
U.S. Market opens in 23h 5m

Atlantic International Corp. (ATLN) Stock Overview

Explore Atlantic International Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap134.9M
P/E Ratio-1.57
EPS (TTM)$-1.08
ROE2.74%
Fundamental Analysis

AI Price Forecasts

1 Month$4.36
3 Months$0.00
1 Year Target$0.00

ATLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Atlantic International Corp. (ATLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 27.71, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.57 and a market capitalization of 134.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.13%
5-Day Change
-18.66%
1-Month Change
-50.72%
3-Month Change
-55.96%
6-Month Change
-40.14%
Year-to-Date (YTD) Change
27.82%
1-Year Change
-62.47%
3-Year Change
-90.56%
5-Year Change
-99.06%
All-Time (Max) Change
-99.06%

Contact Information

https://seqll.com
781 460 6016
3 Federal Street, Billerica, MA, 01821

Company Facts

300 Employees
IPO DateAug 27, 2021
CountryUS
Actively Trading

Frequently Asked Questions